Hims & Hers Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $128.4M | $126.0M | $-23.5M | $-65.7M | $-107.7M | $-18.1M | $-72.1M |
| Depreciation & Amortization | $54.5M | $17.1M | $9.5M | $7.5M | $4.1M | $1.1M | $260.0K |
| Depreciation | — | — | — | — | — | — | — |
| Amortization | $23.7M | $3.8M | $3.5M | $4.1M | $2.1M | $100.0K | $100.0K |
| Stock-Based Compensation | $135.2M | $92.3M | $66.1M | $42.8M | $67.2M | $5.8M | $8.0M |
| Net Cash from Operating Activities | $300.0M | $251.1M | $73.5M | $-26.5M | $-34.4M | $-2.5M | $-74.9M |
| Investing Activities | |||||||
| Capital Expenditures | $242.6M | $52.8M | $26.5M | $7.2M | — | — | — |
| Business Acquisitions | $145.2M | $15.4M | $0 | $0 | $46.5M | $0 | $0 |
| Net Cash from Investing Activities | $-1.02B | $-19.0M | $-12.1M | $34.7M | $-156.3M | $-39.7M | $-39.3M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | $90.0M | $83.0M | $2.0M | $0 | $0 | $0 | $0 |
| Net Cash from Financing Activities | $729.6M | $-107.8M | $-11.5M | $-33.1M | $235.0M | $47.7M | $95.3M |
| Net Change in Cash | $7.2M | $123.9M | $49.9M | $-25.0M | $44.3M | $5.6M | $-18.9M |
| Free Cash Flow | $57.4M | $198.3M | $47.0M | $-33.7M | — | — | — |